Medtronic puts faith in Chinese market
This article was originally published in Clinica
Executive Summary
Medtronic has been given permission by the Chinese authorities to set up a wholly foreign owned enterprise and will establish a new manufacturing plant and offices in Shanghai's Zhangjiang Hi-Tech Park. Construction of the production facility is scheduled to start this summer, with assembly of cardiac pacemakers expected to be under way in mid-1997. The first product will be Medtronic's Champion pacing system.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.